US Bancorp’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,001
Closed -$2.42K 4182
2025
Q1
$2.42K Hold
3,001
﹤0.01% 3835
2024
Q4
$4.14K Hold
3,001
﹤0.01% 3696
2024
Q3
$3.12K Hold
3,001
﹤0.01% 3688
2024
Q2
$5.19K Buy
+3,001
New +$6.04K ﹤0.01% 3501
2023
Q4
Sell
-260
Closed -$972 3996
2023
Q3
$972 Buy
+260
New +$1.2K ﹤0.01% 3769
2023
Q2
Sell
-285
Closed -$1.95K 4010
2023
Q1
$1.95K Sell
285
-1,000
-78% -$7.76K ﹤0.01% 3762
2022
Q4
$10.2K Sell
1,285
-43
-3% -$331 ﹤0.01% 3293
2022
Q3
$13K Buy
1,328
+43
+3% +$435 ﹤0.01% 3253
2022
Q2
$9K Sell
1,285
-2,083
-62% -$18.1K ﹤0.01% 3386
2022
Q1
$44K Sell
3,368
-473
-12% -$6.01K ﹤0.01% 2690
2021
Q4
$61K Buy
3,841
+400
+12% +$7K ﹤0.01% 2541
2021
Q3
$55K Sell
3,441
-1,965
-36% -$28.8K ﹤0.01% 2596
2021
Q2
$75K Buy
5,406
+2,566
+90% +$36.3K ﹤0.01% 2461
2021
Q1
$41K Hold
2,840
﹤0.01% 2677
2020
Q4
$49K Hold
2,840
﹤0.01% 2517
2020
Q3
$52K Buy
2,840
+215
+8% +$4K ﹤0.01% 2377
2020
Q2
$47K Buy
+2,625
New +$44.4K ﹤0.01% 2448
2017
Q4
Sell
-10
Closed 3602
2017
Q3
$0 Buy
+10
New +$132 ﹤0.01% 3576

Other funds holding CHRS